Baxter International Inc. $BAX Shares Bought by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC raised its stake in Baxter International Inc. (NYSE:BAX – Free Report) by 37.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 171,400 shares of the medical instruments supplier’s stock after buying an additional 46,535 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Baxter International were worth $4,114,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. BlackRock Inc. acquired a new stake in shares of Baxter International in the 2nd quarter worth $1,744,874,000. Pzena Investment Management LLC acquired a new position in shares of Baxter International during the 2nd quarter valued at about $1,392,098,000. Equity Investment Corp acquired a new position in shares of Baxter International during the 2nd quarter valued at about $146,815,000. Bank of America Corp DE purchased a new stake in shares of Baxter International in the second quarter valued at about $132,993,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Baxter International in the second quarter valued at about $68,036,000. 90.19% of the stock is owned by institutional investors and hedge funds.

Baxter International Stock Up 0.9%

Shares of NYSE BAX opened at $25.77 on Wednesday. Baxter International Inc. has a 52-week low of $15.73 and a 52-week high of $30.00. The business’s 50 day moving average is $24.55 and its two-hundred day moving average is $21.73. The firm has a market cap of $13.33 billion, a price-to-earnings ratio of 13.16, a PEG ratio of 3.75 and a beta of 0.68. The company has a quick ratio of 1.19, a current ratio of 1.79 and a debt-to-equity ratio of 1.20.

Baxter International (NYSE:BAX – Get Free Report) last issued its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.06. Baxter International had a positive return on equity of 16.23% and a negative net margin of 6.23%. The business had revenue of $2.98 billion during the quarter, compared to analysts’ expectations of $2.91 billion. During the same period in the previous year, the firm posted $0.69 earnings per share. The company’s revenue was up 5.0% on a year-over-year basis. Research analysts predict that Baxter International Inc. will post 2.10 EPS for the current year.

Baxter International Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, November 27th will be paid a dividend of $0.01 per share. The ex-dividend date is Friday, November 27th. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. Baxter International’s dividend payout ratio is -2.84%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on BAX shares. Zacks Research upgraded shares of Baxter International from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 11th. JPMorgan Chase & Co. decreased their target price on shares of Baxter International from $26.00 to $25.00 and set a “neutral” rating on the stock in a report on Friday, October 30th. Barclays increased their price target on shares of Baxter International from $20.00 to $23.00 and gave the company an “underweight” rating in a research note on Monday, November 9th. Wolfe Research assumed coverage on shares of Baxter International in a research note on Tuesday, October 20th. They issued a “peer perform” rating for the company. Finally, Jefferies Financial Group restated a “hold” rating and set a $25.00 price target on shares of Baxter International in a report on Thursday, October 29th. One investment analyst has rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Reduce” and an average price target of $23.27.

Read Our Latest Report on Baxter International

About Baxter International

(Free Report)

Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.

Further Reading

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX – Free Report).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.